Voronoi Inc
KOSDAQ:310210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Voronoi Inc
Intangible Assets
Voronoi Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Intangible Assets
₩1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Intangible Assets
₩1.9T
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Intangible Assets
₩1.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Intangible Assets
₩119.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
181%
|
CAGR 10-Years
95%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Intangible Assets
₩2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Intangible Assets
₩32.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Voronoi Inc
Glance View
Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
See Also
What is Voronoi Inc's Intangible Assets?
Intangible Assets
1B
KRW
Based on the financial report for Dec 31, 2024, Voronoi Inc's Intangible Assets amounts to 1B KRW.
What is Voronoi Inc's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
-37%
Over the last year, the Intangible Assets growth was 11%. The average annual Intangible Assets growth rates for Voronoi Inc have been -21% over the past three years , -37% over the past five years .
